Table of Contents for the Digital Edition of Pharmaceutical Technology - September 2012 Pharmaceutical Technology - September 2012 Contents Joint Regulatory Conferences Europe Hones in on Antitrust Violations Compliant or Contraband? In the Field In the Spotlight Campaign Mounts to Curb Counterfeit Drugs Temperature-controlled Shippers Process Analytical Technology: Charting Progress in Data Analysis Future Innovation in Drug Delivery Classifying Rouge Helps Define Remediation Procedures Achieving Stereoselectivity in APIs and Pharma Intermediates Numerical Simulation of Tablet Coating 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole Early Development GMPs for Stability: An Industry Perspective (Part IV) Correlating Product Lifecycle and Manufacturing Site Characteristics With Critical-to-Quality Product Deviations USP Further Strengthens Quality Standards for Heparin The Macro View Industry Pipeline Showcase/Marketplace Ad Index Technology Transfer: Protecting the True Public Interest Pharmaceutical Technology - September 2012 Pharmaceutical Technology - September 2012 - (Page Cvrtip1) Pharmaceutical Technology - September 2012 - (Page Cvrtip2) Pharmaceutical Technology - September 2012 - Pharmaceutical Technology - September 2012 (Page Cover1) Pharmaceutical Technology - September 2012 - Pharmaceutical Technology - September 2012 (Page Cover2) Pharmaceutical Technology - September 2012 - Pharmaceutical Technology - September 2012 (Page 3) Pharmaceutical Technology - September 2012 - Pharmaceutical Technology - September 2012 (Page 4) Pharmaceutical Technology - September 2012 - Pharmaceutical Technology - September 2012 (Page 5) Pharmaceutical Technology - September 2012 - Pharmaceutical Technology - September 2012 (Page 6) Pharmaceutical Technology - September 2012 - Pharmaceutical Technology - September 2012 (Page 7) Pharmaceutical Technology - September 2012 - Contents (Page 8) Pharmaceutical Technology - September 2012 - Contents (Page 9) Pharmaceutical Technology - September 2012 - Contents (Page 10) Pharmaceutical Technology - September 2012 - Contents (Page 11) Pharmaceutical Technology - September 2012 - Joint Regulatory Conferences (Page 12) Pharmaceutical Technology - September 2012 - Joint Regulatory Conferences (Page 13) Pharmaceutical Technology - September 2012 - Europe Hones in on Antitrust Violations (Page 14) Pharmaceutical Technology - September 2012 - Europe Hones in on Antitrust Violations (Page 15) Pharmaceutical Technology - September 2012 - Compliant or Contraband? (Page 16) Pharmaceutical Technology - September 2012 - Compliant or Contraband? (Page 17) Pharmaceutical Technology - September 2012 - In the Field (Page 18) Pharmaceutical Technology - September 2012 - In the Field (Page 19) Pharmaceutical Technology - September 2012 - In the Field (Page 20) Pharmaceutical Technology - September 2012 - In the Field (Page 21) Pharmaceutical Technology - September 2012 - In the Field (Page 22) Pharmaceutical Technology - September 2012 - In the Field (Page 23) Pharmaceutical Technology - September 2012 - In the Field (Page 24) Pharmaceutical Technology - September 2012 - In the Field (Page 25) Pharmaceutical Technology - September 2012 - In the Field (Page 26) Pharmaceutical Technology - September 2012 - In the Field (Page 27) Pharmaceutical Technology - September 2012 - In the Spotlight (Page 28) Pharmaceutical Technology - September 2012 - In the Spotlight (Page 29) Pharmaceutical Technology - September 2012 - Campaign Mounts to Curb Counterfeit Drugs (Page 30) Pharmaceutical Technology - September 2012 - Campaign Mounts to Curb Counterfeit Drugs (Page 31) Pharmaceutical Technology - September 2012 - Campaign Mounts to Curb Counterfeit Drugs (Page 32) Pharmaceutical Technology - September 2012 - Campaign Mounts to Curb Counterfeit Drugs (Page 33) Pharmaceutical Technology - September 2012 - Temperature-controlled Shippers (Page 34) Pharmaceutical Technology - September 2012 - Temperature-controlled Shippers (Page 35) Pharmaceutical Technology - September 2012 - Temperature-controlled Shippers (Page 36) Pharmaceutical Technology - September 2012 - Temperature-controlled Shippers (Page 37) Pharmaceutical Technology - September 2012 - Process Analytical Technology: Charting Progress in Data Analysis (Page 38) Pharmaceutical Technology - September 2012 - Process Analytical Technology: Charting Progress in Data Analysis (Page 39) Pharmaceutical Technology - September 2012 - Process Analytical Technology: Charting Progress in Data Analysis (Page 40) Pharmaceutical Technology - September 2012 - Process Analytical Technology: Charting Progress in Data Analysis (Page 41) Pharmaceutical Technology - September 2012 - Future Innovation in Drug Delivery (Page 42) Pharmaceutical Technology - September 2012 - Future Innovation in Drug Delivery (Page 43) Pharmaceutical Technology - September 2012 - Future Innovation in Drug Delivery (Page 44) Pharmaceutical Technology - September 2012 - Future Innovation in Drug Delivery (Page 45) Pharmaceutical Technology - September 2012 - Classifying Rouge Helps Define Remediation Procedures (Page 46) Pharmaceutical Technology - September 2012 - Classifying Rouge Helps Define Remediation Procedures (Page 47) Pharmaceutical Technology - September 2012 - Achieving Stereoselectivity in APIs and Pharma Intermediates (Page 48) Pharmaceutical Technology - September 2012 - Achieving Stereoselectivity in APIs and Pharma Intermediates (Page 49) Pharmaceutical Technology - September 2012 - Achieving Stereoselectivity in APIs and Pharma Intermediates (Page 50) Pharmaceutical Technology - September 2012 - Achieving Stereoselectivity in APIs and Pharma Intermediates (Page 51) Pharmaceutical Technology - September 2012 - Numerical Simulation of Tablet Coating (Page 52) Pharmaceutical Technology - September 2012 - Numerical Simulation of Tablet Coating (Page 53) Pharmaceutical Technology - September 2012 - Numerical Simulation of Tablet Coating (Page 54) Pharmaceutical Technology - September 2012 - Numerical Simulation of Tablet Coating (Page 55) Pharmaceutical Technology - September 2012 - 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole (Page 56) Pharmaceutical Technology - September 2012 - 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole (Page 57) Pharmaceutical Technology - September 2012 - 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole (Page 58) Pharmaceutical Technology - September 2012 - 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole (Page 59) Pharmaceutical Technology - September 2012 - 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole (Page 60) Pharmaceutical Technology - September 2012 - 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole (Page 61) Pharmaceutical Technology - September 2012 - 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole (Page 62) Pharmaceutical Technology - September 2012 - 2,4,6-Tribromoanisole and 2,4,6-Trichloroanisole (Page 63) Pharmaceutical Technology - September 2012 - Early Development GMPs for Stability: An Industry Perspective (Part IV) (Page 64) Pharmaceutical Technology - September 2012 - Early Development GMPs for Stability: An Industry Perspective (Part IV) (Page 65) Pharmaceutical Technology - September 2012 - Early Development GMPs for Stability: An Industry Perspective (Part IV) (Page 66) Pharmaceutical Technology - September 2012 - Early Development GMPs for Stability: An Industry Perspective (Part IV) (Page 67) Pharmaceutical Technology - September 2012 - Early Development GMPs for Stability: An Industry Perspective (Part IV) (Page 68) Pharmaceutical Technology - September 2012 - Early Development GMPs for Stability: An Industry Perspective (Part IV) (Page 69) Pharmaceutical Technology - September 2012 - Early Development GMPs for Stability: An Industry Perspective (Part IV) (Page 70) Pharmaceutical Technology - September 2012 - Early Development GMPs for Stability: An Industry Perspective (Part IV) (Page 71) Pharmaceutical Technology - September 2012 - Correlating Product Lifecycle and Manufacturing Site Characteristics With Critical-to-Quality Product Deviations (Page 72) Pharmaceutical Technology - September 2012 - Correlating Product Lifecycle and Manufacturing Site Characteristics With Critical-to-Quality Product Deviations (Page 73) Pharmaceutical Technology - September 2012 - Correlating Product Lifecycle and Manufacturing Site Characteristics With Critical-to-Quality Product Deviations (Page 74) Pharmaceutical Technology - September 2012 - Correlating Product Lifecycle and Manufacturing Site Characteristics With Critical-to-Quality Product Deviations (Page 75) Pharmaceutical Technology - September 2012 - USP Further Strengthens Quality Standards for Heparin (Page 76) Pharmaceutical Technology - September 2012 - USP Further Strengthens Quality Standards for Heparin (Page 77) Pharmaceutical Technology - September 2012 - The Macro View (Page 78) Pharmaceutical Technology - September 2012 - The Macro View (Page 79) Pharmaceutical Technology - September 2012 - The Macro View (Page 80) Pharmaceutical Technology - September 2012 - The Macro View (Page 81) Pharmaceutical Technology - September 2012 - Industry Pipeline (Page 82) Pharmaceutical Technology - September 2012 - Industry Pipeline (Page 83) Pharmaceutical Technology - September 2012 - Industry Pipeline (Page 84) Pharmaceutical Technology - September 2012 - Showcase/Marketplace (Page 85) Pharmaceutical Technology - September 2012 - Showcase/Marketplace (Page 86) Pharmaceutical Technology - September 2012 - Showcase/Marketplace (Page 87) Pharmaceutical Technology - September 2012 - Showcase/Marketplace (Page 88) Pharmaceutical Technology - September 2012 - Ad Index (Page 89) Pharmaceutical Technology - September 2012 - Technology Transfer: Protecting the True Public Interest (Page 90) Pharmaceutical Technology - September 2012 - Technology Transfer: Protecting the True Public Interest (Page Cover3) Pharmaceutical Technology - September 2012 - Technology Transfer: Protecting the True Public Interest (Page Cover4) http://digital.findpharma.com/nxtbooks/advanstar/pt_201302 http://digital.findpharma.com/nxtbooks/advanstar/pt_201301 http://digital.findpharma.com/nxtbooks/advanstar/pt_201212 http://digital.findpharma.com/nxtbooks/advanstar/pt_201211_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201211 http://digital.findpharma.com/nxtbooks/advanstar/pt_201210 http://digital.findpharma.com/nxtbooks/advanstar/pt_201209_basf http://digital.findpharma.com/nxtbooks/advanstar/pt_201209_cphi http://digital.findpharma.com/nxtbooks/advanstar/pt_201209 http://digital.findpharma.com/nxtbooks/advanstar/pt_201208 http://digital.findpharma.com/nxtbooks/advanstar/pt_201208_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201207 http://digital.findpharma.com/nxtbooks/advanstar/pt_201206 http://digital.findpharma.com/nxtbooks/advanstar/pt_201205_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201205 http://digital.findpharma.com/nxtbooks/advanstar/pt_201204 http://digital.findpharma.com/nxtbooks/advanstar/pt_201203_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201203 http://digital.findpharma.com/nxtbooks/advanstar/pt_201202_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201202 http://digital.findpharma.com/nxtbooks/advanstar/pt_201201 http://digital.findpharma.com/nxtbooks/advanstar/pt_201112 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201110 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201108 http://digital.findpharma.com/nxtbooks/advanstar/pt_201108_supplmnt http://digital.findpharma.com/nxtbooks/advanstar/pt_201107 http://digital.findpharma.com/nxtbooks/advanstar/pt_201106 http://digital.findpharma.com/nxtbooks/advanstar/pt_201105_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201105 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201103 http://digital.findpharma.com/nxtbooks/advanstar/pt_201102 http://digital.findpharma.com/nxtbooks/advanstar/pt_201101 http://digital.findpharma.com/nxtbooks/advanstar/pt_201012 http://digital.findpharma.com/nxtbooks/advanstar/pt_201011 http://digital.findpharma.com/nxtbooks/advanstar/pt_201010 http://digital.findpharma.com/nxtbooks/advanstar/pt_201009 http://digital.findpharma.com/nxtbooks/advanstar/pt_201008 http://digital.findpharma.com/nxtbooks/advanstar/pt_201007 http://digital.findpharma.com/nxtbooks/advanstar/pt_201006 http://digital.findpharma.com/nxtbooks/advanstar/pt_201005 http://digital.findpharma.com/nxtbooks/advanstar/pt_201004 http://digital.findpharma.com/nxtbooks/advanstar/pt_201003 http://digital.findpharma.com/nxtbooks/advanstar/pt201002 http://digital.findpharma.com/nxtbooks/advanstar/pt_201001 http://digital.findpharma.com/nxtbooks/advanstar/pt_200912 http://digital.findpharma.com/nxtbooks/advanstar/pt_200911 http://digital.findpharma.com/nxtbooks/advanstar/pt10_2009 http://digital.findpharma.com/nxtbooks/advanstar/pt_200909 http://digital.findpharma.com/nxtbooks/advanstar/pt_200908 http://digital.findpharma.com/nxtbooks/advanstar/pt_200907 http://digital.findpharma.com/nxtbooks/advanstar/pt_200906 http://digital.findpharma.com/nxtbooks/advanstar/pt_200905 http://www.nxtbook.com/nxtbooks/advanstar/pt_200904 http://www.nxtbook.com/nxtbooks/advanstar/pt_200903 http://www.nxtbook.com/nxtbooks/advanstar/pt_200902 http://www.nxtbook.com/nxtbooks/advanstar/pt_200901 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.